From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Dermatology>
  4. Summary and Comment

Curettage and Electrodesiccation of Low-Risk SCCs Apparently Effective in Organ Transplant Recipients

Nevertheless, more aggressive treatment may still be warranted.

Organ transplant recipients (OTRs) require a chronic course of immunosuppressive agents. With time, they are prone to develop nonmelanoma skin cancers, particularly squamous cell carcinoma (SCC). The traditional teaching has been that because SCC in an OTR has a high risk for recurrence, the initial lesion requires aggressive therapy.

Investigators examined the rates of residual tumor and recurrence in 48 OTRs who had 211 "low-risk" SCCs treated with curettage and electrodesiccation. Lesions were considered low risk if they were smaller than 2 cm in diameter and did not infiltrate into deep tissues. After treatment, the patients were followed for a mean of 73 months. Ten patients had residual or recurrent disease (13 treated lesions [6%]). Eleven percent of residual or recurrent lesions were on the head and neck; 7% on the dorsal hands and fingers; and 5% on other sites, with none on the forearms. The risk for recurrence was greatest in the first 12 months. The authors consider such rates to be acceptable enough to justify the use of this quick and inexpensive treatment.

Comment: These findings may appear to question the routine use of more aggressive, time-consuming, and costly procedures in organ transplant recipients with squamous cell carcinomas. However, because recurrences are often more invasive, recurrence rates in the 7%-to-11% range seem excessive and warrant more-aggressive procedures like micrographic surgery, at least for lesions of the head and neck. Nonmelanoma skin cancer in an organ transplant recipient should be carefully assessed, treated, and followed.

— Jeffrey P. Callen, MD

Published in Journal Watch Dermatology February 28, 2006

Citation(s):

De Graaf YGL et al. The occurrence of residual or recurrent squamous cell carcinomas in organ transplant recipients after curettage and electrodesiccation. Br J Dermatol 2006 Mar; 154:493-7.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2006. Massachusetts Medical Society. All rights reserved.